Day TwoWednesday, 25 March 2026 - Western European Summer Time (WEST)

The digital revolution has well and truly reached Pharma. Some pharmaceutical companies are at the forefront of digital transformation, using innovative technology to accelerate drug discovery, boost patient adherence and drive better outcomes. This panel examines how leading pharma companies are adapting to the digital revolution, their implementation strategies, and lessons that can be learned from their successes and challenges.

• Which companies are leading the way in adapting to digital transformation
• How industry leaders are implementing digital strategies
• Best practices and lessons learned from digital pioneers

The pharmaceutical industry is witnessing a transformation in how partnerships are formed and maintained. Traditional collaboration models are evolving to create more mutually beneficial relationships between startups, established pharmaceutical companies, and health systems. These new partnership models are driving innovation while distributing risk and maximizing resources across the ecosystem.

• Building effective coalitions between startups, pharma, and government organizations
• Case studies of successful non-traditional partnerships
• Strategies for creating sustainable win-win collaborations in the pharmatech space

Significant differences exist between European and American markets in digital health adoption. This panel examines cultural factors affecting technology usage and trust, demographic influences on adoption rates, and strategic considerations for digital health launches. Understanding these regional differences is crucial for companies planning global digital health initiatives.

• Cultural and demographic differences in usage and trust
• Strategies for successful market entry in the US
• Strategic considerations for where best to launch digital health solutions

Digital technologies can significantly enhance traditional pharmaceutical therapies by improving outcomes and usage. Join our panel of pharma leaders and investors to hear how technological solutions can complement conventional medicines, with a particular focus on mobile applications and other digital companions to traditional treatments.

• How tech can supplement traditional therapies to benefit patients
• The role of mobile applications in supporting medication adherence
• The value in developing effective digital companions for pharmaceutical products

Digital technologies are revolutionizing clinical trial processes from recruitment through completion. This panel of experts explore how digital solutions improve participant recruitment, monitoring, data consolidation, and treatment adherence. These innovations are making trials more efficient, cost-effective, and patient-centred.

• Digital benefits in recruitment, monitoring, data consolidation, adherence
• Technologies improving patient experience in clinical trials
• Overcoming implementation challenges in digital clinical trial management

Successful AI implementation in pharmaceutical settings requires much more than just advanced technology. This panel explores why technology is not the be all and end all of successful AI implementation, with organizational and behavioural factors playing a key role in the success or failure of adopted technology. Strategies for effective workflow integration and staff adaptation are critical for realizing AI's full potential.

• Why technology is just the start of successful AI implementation
• Strategies for workflow integration and staff retraining
• Addressing behavioural change in pharmaceutical organizations

Integrating AI into clinical workflows presents both significant opportunities and challenges. Our group of experts explore these pros and cons and share practical approaches to AI implementation in clinical settings, strategies for addressing workforce concerns about automation, and showcases successful case studies of AI adoption in clinical operations.

• Integrating AI into existing clinical workflows

• Addressing job displacement fears and workforce transformation

• Case studies of successful AI implementation in clinical settings

Venture capital plays a crucial role in accelerating innovation within the life sciences, and pharmatech is no different. Our panel of investors examine how VCs are driving digital transformation in the pharmaceutical industry, funding strategies specifically for AI-focused startups, and approaches to balance immediate returns with long-term value creation.

• The role of VC in driving innovation in pharmatech
• Funding strategies for AI-focused pharma startups
• Balancing short-term wins with long-term value creation